BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

EarlySense Receives FDA Clearance and CE Approval for the Wireless Network Option of its Contact-Free Patient Monitoring Solution


6/13/2011 6:45:52 AM

RAMAT GAN, Israel--(BUSINESS WIRE)-- EarlySense, which is currently bringing to market the most advanced, contact-free, patient monitoring solution for hospitals and nursing homes, announced today that it has received FDA clearance and CE approval for the new wireless (WiFi) communications component of its solution. The WiFi system wirelessly connects the bedside unit of the solution to the Central Display System at the nurses’ station.

EarlySense’s contact-free patient monitoring system, which was FDA cleared and CE approved in 2010, automatically and continuously monitors a patient’s vital signs and movement, from the moment the patient enters the bed, using a contact-free sensor that is placed under the mattress. The system records and documents the cardiac, respiratory, and motion parameters for a full hospital unit. It alerts staff when significant changes in a patient’s condition take place, as well as when a patient needs turning to avoid pressure ulcers or is leaving the bed and is in danger of falling. Nurses are informed of patient status changes on the patient’s bed side monitor, at the nurse’s station, on their mobile phones and on a large screen display mounted in a prominent spot on the wall in the department.

EarlySense CEO Avner Halperin said, "One of our goals at EarlySense is to continuously improve on the ease of use and installation of our solution, while simultaneously adhering to the strictest protocols on data integrity, security and privacy. The WiFi communication system makes installation extremely simple, as it eliminates the need for a hardwired infrastructure network. This means, that our patient monitoring system is not only contact-free, in terms of never touching the patient, but is now also almost infrastructure-free.”

EarlySense also announced today that the company has received an ISO 13485 Certificate. This confirms the company’s compliance with the highest international regulatory requirements.

“ISO 13485 approval is a very important milestone for us. Receipt of this status reaffirms EarlySense’s commitment to the highest level of quality both in the design and manufacturing of our patient monitoring system as we continue to serve our customers with creative, cutting edge solutions,” said Dalia Argaman, EarlySense’s vice president of clinical and regulatory affairs.

About EarlySense

EarlySense is bringing to market an innovative technology designed to advance proactive and preventive patient supervision to enable better patient outcomes. The company’s flagship product is an automatic, continuous, contact-free, patient monitoring solution that follows and documents a patient’s vital signs and movement. There are no leads or cuffs to connect to the patient, who has complete freedom of movement and is not burdened by any irritating attachments. The system is currently installed at several medical centers in the United States and Europe. EarlySense is headquartered in Ramat-Gan, Israel and has announced plans to locate a U.S. headquarters in Massachusetts. For additional information, please visit www.earlysense.com.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES